| P2093 | author name string | David E Nichols | |
| | Jennifer Selken | |
| P2860 | cites work | Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin | Q28143430 |
| | Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse | Q28143940 |
| | Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice | Q28240337 |
| | 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex | Q28371748 |
| | Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates | Q28510256 |
| | Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. | Q33871547 |
| | The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 |
| | Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors | Q34316202 |
| | [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues | Q34549018 |
| | Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain | Q34559625 |
| | Altered states: the clinical effects of Ecstasy. | Q35095703 |
| | Acute Psychological and Neurophysiological Effects of MDMA in Humans | Q35105559 |
| | Multiple molecular and neuropharmacological effects of MDMA (Ecstasy). | Q35601892 |
| | Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats | Q36823553 |
| | Absolute configuration and psychotomimetic activity | Q39630453 |
| | Comparison of the effects of methoxamine with those of noradrenaline and phenylephrine on single cerebral cortical neurones | Q39934189 |
| | Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). | Q40563105 |
| | International Union of Pharmacology nomenclature of adrenoceptors | Q40638526 |
| | The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries | Q41066864 |
| | Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist | Q41987439 |
| | Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. | Q42202646 |
| | Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine | Q42274823 |
| | Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection | Q42281730 |
| | The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. | Q42515391 |
| | Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat. | Q42601368 |
| | Modulation of MK-801-induced behaviour by noradrenergic agents in mice | Q43583552 |
| | Cortical alpha 1-adrenergic regulation of acute and sensitized morphine locomotor effects | Q43815918 |
| | Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics | Q43825633 |
| | Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors | Q43829046 |
| | Increasing MDMA use among college students: results of a national survey | Q43833142 |
| | Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by prazosin. | Q44225215 |
| | Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors. | Q44515585 |
| | A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. | Q45071429 |
| | Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. | Q45072510 |
| | Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats | Q46122756 |
| | Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine | Q46372813 |
| | Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats | Q48091266 |
| | The role of alpha-1 adrenergic receptors in the stimulating effect of neuropeptide Y (NPY) on rat behavioural activity | Q48151967 |
| | Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. | Q48159213 |
| | Functional supersensitivity to the alpha 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta-down-regulation | Q48202847 |
| | Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices | Q48328073 |
| | Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. | Q48493259 |
| | Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex | Q48580875 |
| | Electroconvulsive shock increases alpha 1b- but not alpha 1a-adrenoceptor binding sites in rat cerebral cortex | Q48635872 |
| | Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens | Q48950280 |
| | Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission | Q48956942 |
| | Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum | Q48957620 |
| | Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats | Q49068866 |
| | Radioreceptor binding profile of the atypical antipsychotic olanzapine | Q49130929 |
| | Thigmotaxis as a test for anxiolytic activity in rats. | Q51183679 |
| | Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. | Q51820585 |
| | Alpha1‐adrenergic Effects on Dopamine Neurons Recorded Intracellularly in the Rat Midbrain Slice | Q52334853 |
| | Comparison of the neuronal responses to 5-hydroxytryptamine, noradrenaline and phenylephrine in the cerebral cortex: Effects of haloperidol and methysergide | Q70277109 |
| | Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats | Q70853211 |
| | Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected] | Q72191376 |
| | Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex | Q72334786 |
| | Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat | Q72927051 |
| | Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors | Q73704526 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 622-630 | |
| P577 | publication date | 2007-02-16 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats | |
| P478 | volume | 86 | |